Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 21 results found. Search for [ drug pricing pressures ]

Results 1 to 21 of 21
PB Jayakumar
August 6, 2020
Though margins remain healthy, pricing pressures for the US base generics business, lack of limited competition products and manufacturing quality issues will continue to trouble them, said ICRA


E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


PTI
April 1, 2019



E Kumar Sharma
January 18, 2019
Globally, the number of diabetes patients is at around half a billion with over 30 million in the US alone, the most sought after market for diabetes care companies, especially those into insulin.


E Kumar Sharma
November 13, 2018
At the moment most experts are in a wait and watch mode, while some players from these sectors think that it could be a mixed bag.


E. Kumar Sharma
New Delhi, October 29, 2018
Strides Pharma Science attributes its underwhelming performance to a confluence of headwinds and execution challenges.


PTI
October 2, 2018



E Kumar Sharma
New Delhi, February 25, 2018
Once known for the books it sold, the e-commerce behemoth has today permeated most lives with products to meet everyday needs - from grocery to gadgets, movies to now even medicines.


E. Kumar Sharma
New Delhi, November 25, 2017
Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.


E Kumar Sharma
New Delhi, August 28, 2017
The most striking thing about the policy draft is, that it has good policy goals but gives little thought on the road map and challenges in meeting them.


Mahesh Nayak
Delhi, July 8, 2017
With stock markets at a record high, fund managers are having a difficult time finding value stocks to deploy the record inflows


E. Kumar Sharma
New Delhi, June 10, 2017
Dr. Reddy's says it has a plan and a product pipeline to drive growth in spite of regulatory and other challenges. Can it pull it off?


E Kumar Sharma
January 2, 2017
What can the Indian pharma companies hope to look forward to in the new year? After all, market headwinds in the form of drug pricing pressures , both in India and the US, and regulatory compliance issues are expected to continue even in 2017. Some of the industry veterans feel a greater focus on smart portfolio choices will get even more critical in 2017. 


By E. Kumar Sharma,E Kumar Sharma
Delhi, October 29, 2016
Many major pharma stocks, seen as safe bets in the worst of times, have seen their market caps slip in the past year. Is pharma losing its sheen on the bourses?


Zeba Siddiqui
July 14, 2014
India last year raised the number of drugs that are subject to price controls to cover up to 30 per cent of the total medication sold in the country, according to industry officials.


E. Kumar Sharma
May 7, 2014
This is for the first time, analysts point out, that Lupin has reported a below industry average growth in its India business. It now remains to be seen what corrective actions Lupin puts in place and what its India outlook is going to be going forward.


PTI
New Delhi, April 11, 2013
Painting a favourable picture for the domestic pharmaceutical companies, ICRA said balance sheets of major pharmaceutical companies remain strong and provide adequate room for fund raising if required.


E. Kumar Sharma
April 13, 2013
The Supreme Court decision on Glivec sets the tone for other patent disputes and puts global drugmakers on the back foot.


www.businesstoday.in
December 28, 2006
This selection of research reports gives information and opinions on companies and industries.


T.V. Mahalingam
November 13, 2008
Export-dependent IT, biotech and pharma firms have their backs to the wall with the rupee gyrating and their overseas markets in turmoil. When will the markets look up again? T.V. Mahalingam goes into the details.


PAGES 1 OF 2  12